Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Jul 28, 2022; 14(7): 194-208
Published online Jul 28, 2022. doi: 10.4329/wjr.v14.i7.194
Published online Jul 28, 2022. doi: 10.4329/wjr.v14.i7.194
Molecular imaging as a tool for evaluation of COVID-19 sequelae – A review of literature
Kunal R Chandekar, Swayamjeet Satapathy, Harmandeep Singh, Anish Bhattacharya, Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
Author contributions: Chandekar KR wrote the initial draft of the manuscript and prepared the figures; Satapathy S was responsible for idea conception and design of the manuscript; Singh H was in charge of editing the manuscript; and Bhattacharya A provided critical inputs and helped in the final revision.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Swayamjeet Satapathy, MBBS, MD, Doctor, Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Sector-12, Chandigarh 160012, India. swayamjeet.satapathy@gmail.com
Received: February 22, 2022
Peer-review started: February 22, 2022
First decision: April 28, 2022
Revised: May 17, 2022
Accepted: July 11, 2022
Article in press: July 11, 2022
Published online: July 28, 2022
Processing time: 154 Days and 16.1 Hours
Peer-review started: February 22, 2022
First decision: April 28, 2022
Revised: May 17, 2022
Accepted: July 11, 2022
Article in press: July 11, 2022
Published online: July 28, 2022
Processing time: 154 Days and 16.1 Hours
Core Tip
Core Tip: Despite extensive global efforts, coronavirus disease 2019 (COVID-19) remains the largest public health problem of modern times. As our understanding of the disease and its manifestations improve, we must recognize and explore the potential utility of molecular imaging modalities in evaluating the long-term sequelae of COVID-19. Molecular imaging tools can be incorporated into routine clinical practice by identifying appropriate and specific indications and addressing limitations to their practical application.